Advertisement

ASH 2022: Re-evaluating the Standard of Care in Mantle Cell Lymphoma
Posted: 12/13/2022 | By: Kayci Reyer

Results of the randomized Triangle trial in younger patients with mantle cell lymphoma were presented by Dreyling et al at the 2022 ASH Annual Meeting and Exposition (Abstract 1).

Question 1 of 5

Which of the following is the current standard of care for younger patients with mantle cell lymphoma?

Choose 1